JAMA Dermatology —The Year in Review, 2025 - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

JAMA Dermatology: Highlights and Developments from 2025

  • By

  • Kanade Shinkai

  • May 1, 2026

Share

Objective:

To summarize the key developments and performance metrics of JAMA Dermatology in 2025.

Key Findings:
  • The impact factor remained high at 11.
  • The article on nicotinamide supplementation showed potential benefits for skin cancer prevention.
  • AI applications in dermatology were highlighted, including studies on wearable devices providing haptic feedback and risk stratification tools for cutaneous squamous cell carcinoma.
Interpretation:

The journal's focus on timely publication and high-quality research continues to enhance its relevance in dermatology.

Limitations:
  • The need for prospective randomized clinical trials to confirm findings on nicotinamide.
  • Potential overdiagnosis issues in melanoma screening were discussed, emphasizing the need for careful evaluation.
Conclusion:

JAMA Dermatology is committed to publishing impactful research that informs clinical practice while adapting to evolving challenges in dermatology.

Original Source(s)

JAMA Dermatology —The Year in Review, 2025

  • by Kanade Shinkai

  • May 1, 2026

Related Content

Topical Recombinant Collagen Following Fractional Radio Frequency Microneedling for Nonsurgical Facelift: Case Report

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

AI Scribes Lag Clinicians on Note Quality

A VHA study across 11 vendors finds AI-generated primary care notes score lower than clinician-written notes, with the largest deficits in thoroughness, organization, and usefulness